Efficacy of Novel Noncontrast Cardiac Magnetic Resonance Methods in Indicating Fibrosis in Hypertrophic Cardiomyopathy
Objective. In hypertrophic cardiomyopathy (HCM), myocardial fibrosis is routinely shown by late gadolinium enhancement (LGE) in cardiac magnetic resonance (CMR) imaging. We evaluated the efficacy of 2 novel contrast-free CMR methods, namely, diffusion-weighted imaging (DWI) and feature-tracking (FT)...
Saved in:
Main Authors: | Maedeh Sharifian, Nahid Rezaeian, Sanaz Asadian, Ali Mohammadzadeh, Ali Nahardani, Kianosh Kasani, Yaser Toloueitabar, Ali Mohammad Farahmand, Leila Hosseini |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2021/9931136 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of genetic mutations on left ventricular myocardial mechanics and fibrosis patterns in hypertrophic cardiomyopathy
by: Minjeong Kim, et al.
Published: (2025-01-01) -
Use of Texture Analysis on Noncontrast MRI in Classification of Early Stage of Liver Fibrosis
by: Ru Zhao, et al.
Published: (2021-01-01) -
Sepsis-induced suicidal left ventricular in a patient with hypertrophic cardiomyopathy/hypertrophic obstructive cardiomyopathy
by: K Roshan Rao, et al.
Published: (2022-01-01) -
Clinical burden of obstructive hypertrophic cardiomyopathy in France
by: Philippe Charron, et al.
Published: (2025-01-01) -
Role of Cardiac Magnetic Resonance in Detecting Biventricular Apical Hypertrophic Cardiomyopathy
by: Nathan Zaher, et al.
Published: (2021-01-01)